Page 405 - Traité de chimie thérapeutique 6 Médicaments antitumoraux

361
15. EPIPODOPHYLLOTOXINES

BEIJNEN J.H., BEIJNEN-BANDHOE A.-U., DUBBELMAN A.-C., VAN GIJN R., UNDER-
BERG J.M., Chemical and Physical Stability of Etoposide and Teniposide in Com-
monly Used Infusion Fluids, J. Parenteral Science and Technology, 1991, 45, 108-112.

DONNÉES PHARMACOCINÉTIQUES
CLARK P.I. SLEVIN M.L., The Clinical Pharmacology of Etoposide and Teniposide, Clin
Pharmacokinet., 1987, 12, 223-252.
HOLTHUIS J.J.M., Etoposide and Teniposide - Bioanalysis, metabolism and clinical
pharmacokinetics, Pharmaceutisch Weekblad Scientific Edition, 1988, 10, 101-116.

MÉCANISME D'ACTION
JARDINE 1., STRIFE R.J., KOZLOWSKI J., Synthesis, 470-MHz 'H NMR Spectra, and
Activity of Delactonized Derivatives of the Anticancer Drug Etoposide, J. Med. Chem.,
1982, 25, 1077-1081.
HAIM N., ROMAN J., NEMEC J, SINHA B.K., Peroxidative free radicals formation and O-
demethylation of etoposide (VP-16) and teniposide (VM-26), Biochem. Biophys. Res.
Commun., 1986, 135, 215-220.
CHOW K.C., MCDONALD T.L., ROSS W.E., DNA Binding by Epipodophyllotoxins and
N-acyl Anthracyclines : Implications for Mechanism of Topoisomerase Il Inhibition,
Mol. Pharmacol., 1988, 34, 467-473.
EICH E., SCHULZ J., KALOGA M., MERZ H., SCHRÔDER H.C., MULLER W.E.J., lnter-
ference of Epidopodophyllotoxins and Natural Lignanolides with Topoisomerase Il: A
Proposed Molecular Mechanism, Planta Med., 1991, 57, supplement issue 2, A7-A8.
GORDALIZA M., DEL CORRAL J.M.M., CASTRO M.A., LOPEZ-VAZQUEZ M.L., SAN
FELICIANO A., GARCIA-GRAVALOS M.D., CARPY A., Synthesis and Evaluation of
Pyrazolignans. A New Glass of Cytotoxic Agents, Bioorg. Med. Chem., 1995, 3, 1203-
1210.
GANTCHEV T.G., HUNTING D.J., The Ortho-Quinone Metabolite of the Anticancer Drug
Etoposide (VP-16) Is a Potent lnhibitor of the Topoisomerase I1/DNA Cleavable Com-
plex, Mol. Pharmacol., 1998, 53, 422-428.

ACTIVITÉ, RELATIONS STRUCTURE-ACTIVITÉ
LONG B.H., STRINGFELLOW D.A., lnhibitors of topoisomerase Il : structure-activity rela-
tionships and mechanism of action of podophyllin congeners, Advances in enzyme
Regulation, 1988, 27, 223-256.
STAHEUN H.F., Von WARTBURG A, The Chemical and Biological Route from Podophyl-
lotoxin Glucoside to Etoposide : Ninth Cain Memorial Award Lecture, Cancer Res.,
1991, 51, 5-15.
LONG B. H., CASAZZA A.M., Structure-Activity relatlonships of VP-16 analogues, Cancer
Chemother. Pharmacol., 1994, 34, S26-S31.
DAMAYANTHI Y., LOWN J.W., Podophyllotoxins: Current Status and Recent Develop-
ments, Current Med. Chem., 1998, 5, 205-252.
DESBENE S., GIORGI-RENAULT S., Drugs that inhibit tubulin polymerization : the par-
ticular case of podophyllotoxin and analogues, Current Med. Chem., Anti-Cancer
Agents, 2002, 2, 71-90.